Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 1009-1021, December 2008

Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer

  • Furio Pacini, MD (Professor of Endocrinology, and Director, Section of Endocrinology and Metabolism, University of Siena, Italy)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39 0577585406; Fax: +39 0577586187.
    • ,
  • Maria Grazia Castagna, MD (Staff Physician, Section of Endocrinology, University Hospital of Siena, Italy)

Department of Internal Medicine, Endocrinology & Metabolism and Biochemistry, Section of Endocrinology & Metabolism, University of Siena, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(08)00111-5

doi:10.1016/j.beem.2008.09.014

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 1009-1021, December 2008

Article Tools

* Image Usage & Resolution